InterCure Ltd (INCR) Company Sales Volume

InterCure Ltd. bases its growth on expanding medical cannabis supplies in Germany and Israel under strict quality control. Regulatory risks and geopolitics create volatility, although cash flows are increasing. Leading positions provide excess liquidity for development. The value of 0.08 captures this metric, which is clearly illustrated through the company's commercial revenue level.

INCR: InterCure Ltd Revenue and Sales Volume 07/04/2022 - 11/15/2026

Comprehensive metric breakdowns and analytics for intercure.co (INCR)

- market value and analyst target forecast:

Market Chart intercure.co|INCR - Price Target Chart

- market capitalization details:

Market Capitalization INCR|INCR - Real Price to Acquire Entire Company

- issuer book value statistics:

Book Price of a Share InterCure|INCR - Book Capitalization|Market-to-Book Ratio intercure.co|INCR - Aggregate Company Assets

- debt obligations and liquidity statistics:

- earnings and valuation multiples information:

INCR - Net Income|Expected Net Income InterCure Ltd.|INCR - Price to Earnings Ratio|Future Price to Earnings InterCure|INCR - Price/Earnings to Growth Multiple|Enterprise Value to Operating Income Before Depreciation Ratio InterCure Ltd|INCR - Operating profit EBITDA|Earnings per share for the last 12 months InterCure|INCR - Net earnings per share for the last 12 months|Year-over-year net earnings per share change for the last twelve months intercure.co|INCR - Earnings growth in current year|Consensus forecast of earnings per share growth for next year InterCure Ltd.

- company sales and revenue statistics:

INCR - Company Revenue|Company Revenue Forecast InterCure Ltd.|INCR - P/S Multiple|Forward Price-to-Revenue Multiple Canndoc|INCR - Sales Growth YoY (Last Twelve Months)

General company analysis:INCR, InterCure Ltd

Professional managers utilize fundamental filters to assess an asset's real liquidity relative to the industry benchmark. This metric captures daily cash inflows from sales, allowing for the identification of market cycle phases and the avoidance of capital freezes. For InterCure Ltd. (INCR), which is scaling its expansion in Europe and Israel, this indicator confirms the effectiveness of exclusive partnerships. By analyzing the company's trading revenue dynamics, an investor assesses the pace of the business's commercial growth.

Analysis of competing companies